Management of chronic viral hepatitis in HIV-infected patients: Spanish Consensus Conference. October 2000.
Co-infection by human immunodeficiency virus and hepatitis B and C viruses is quite common because they share similar routes of transmission. The introduction of highly active antiretroviral therapy has significantly improved the life expectancy of HIV-infected patients in the last few years. However, chronic viral hepatitis represents an emerging cause of morbidity and mortality in this population, either as a result of end-stage liver disease or as a consequence of hepatotoxicity induced by antiretroviral drugs. The main goal of the Consensus Conference was to establish specific recommendations for the management of chronic viral hepatitis B and C in HIV-infected patients. The role of orthotopic liver transplantation for co-infected individuals with end-stage liver disease was also assessed.
García-Samaniego
Javier
J
Hepatology, Hospital Carlos III, Instituto de Salud Carlos III, Madrid, Spain. javiersamaniego@eresmas.net
Soriano
Vicente
V
Miró
José María
JM
Romero
Jorge Del
JD
Bruguera
Miguel
M
Castilla
Jesús
J
Esteban
Juan Ignacio
JI
Gonźlez
Juan
J
Lissen
Eduardo
E
Moreno
Alberto
A
Moreno
Santiago
S
Moreno-Otero
Ricardo
R
Ortega
Enrique
E
Quereda
Carmen
C
Rodríguez
Manuel
M
Sánchez-Tapias
José María
JM
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D019380:Anti-HIV Agents / Q000009:adverse effects / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active; D002986:Clinical Trials as Topic; D005355:Fibrosis / Q000150:complications / Q000188:drug therapy; D019694:Hepatitis B, Chronic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D019698:Hepatitis C, Chronic / Q000188:drug therapy / Q000601:surgery / Q000628:therapy*; D006801:Humans; D016031:Liver Transplantation; D013030:Spain
D019380:Anti-HIV Agents